Disposition of 100 shares by Rebecca Roberts of Black Hills at 54.83 subject to Rule 16b-3
| ABBV Stock | MXN 3,504 57.50 1.61% |
Slightly above 61% of AbbVie's investor base is looking to short. The analysis of current outlook of investing in AbbVie Inc suggests that many traders are alarmed regarding AbbVie's prospects. AbbVie's investing sentiment can be driven by a variety of factors including economic data, AbbVie's earnings reports, geopolitical events, and overall market trends.
AbbVie |
Filed transaction by Black Hills Director. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at macroaxis.com
AbbVie Fundamental Analysis
We analyze AbbVie's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AbbVie using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AbbVie based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Revenue
Revenue Comparative Analysis
AbbVie is rated second in revenue category among its peers. Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
AbbVie Inc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with AbbVie stock to make a market-neutral strategy. Peer analysis of AbbVie could also be used in its relative valuation, which is a method of valuing AbbVie by comparing valuation metrics with similar companies.
Peers
AbbVie Related Equities
| PFE | Pfizer | 0.76 | ||||
| GSKN | GlaxoSmithKline Plc | 0.00 | ||||
| AZNN | AstraZeneca PLC | 1.21 | ||||
| ABBV | AbbVie | 1.61 |
Additional Tools for AbbVie Stock Analysis
When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.